Moreover, it was shown that the use of MIM1-high and specific Mcl-1 inhibitor increased the level of Mcl-1 protein in BRAF-mutant amelanotic C32 melanoma cells with subsequent apoptosis induction [55]. Here, MIMT1 is linked to melanoma.